Sign in
Subscribe
News
Tech trail
Trade floor
Export
The Killer50
Oxford
Blogs
Awards
Directory
Events
A worldwide window to Cambridge business, innovation and technology
Cambridge companies could do with more ambition, says UK tech gospeller Eben Upton
Eben Upton, CEO at Cambridge microcomputer innovator Raspberry Pi, has urged other tech companies in the Cluster to show more ambition in their global growth strategies.
UK and India boost trade by billions via historic deal
The UK and India have today agreed a landmark trade deal. Indian tariffs will be slashed, locking in reductions on 90 per cent of tariff lines, with 85 per cent of these becoming fully tariff-free within a decade.
40 years of the ARM chip: From Cambridge to the world
As tech entrepreneur and Acorn Computers co-founder Hermann Hauser recently reminded me, the ARM chip which made its bow 40 years ago this month was actually christened the Acorn RISC Machine considering where it was founded.
Cambridge duo Mosaic and Astex agree cancer collaboration
Mosaic Therapeutics, a Cambridge-based targeted oncology therapeutics company resolving cancer’s complexity with new combination therapies, has in-licensed two clinical-stage oncology programs from Astex Pharmaceuticals.
Nyobolt recharges its cash batteries with $180m boost and targets $multibillion markets
Nyobolt, a Cambridge-based pioneer of high-power ultrafast charging technologies has secured $150 million in contracts plus $30m in investment from international backers.
Academia
Sharewatch
Manufacturing
IfM Cambridge helps steer electric shipping initiative
05 May 2025 - 12:00
World-first trial indicates immunosuppression may help treat Parkinson’s disease
09 Apr 2025 - 12:00
Magnificent seven funded in Quadram-NNUH healthcare venture
28 Mar 2025 - 12:00
Business awards
Entries now being accepted
Business directory
Browse our listings of Cambridge companies
The killer 50
The 50 hottest disruptive technology companies
News
Isomerase unveils cutting edge enzyme platform
Isomerase has launched EvoSelect®, a machine learning-guided enzyme engineering platform designed to accelerate development timelines, enhance performance under industrial conditions and reduce the cost and complexity of enzyme optimisation.
Heavenly for Cellestial Health as it raises pre-seed funding
Cellestial Health, a pharmaceutical development spin-out from the University of Cambridge, has closed a £515,000 pre-seed equity funding round to accelerate the development of novel therapeutics targeting astrocytes, an often-overlooked cell type in the brain, with the first indication of Parkinson’s disease.
Oxford Innovation Finance invests in cutting-edge sensor technology to optimise crop growth
Oxford Innovation Finance’s EIS Growth Fund and OION Angel Network have invested in Gardin, a first real-time, remote and autonomous crop phenotyping SaaS platform, alongside LDV Capital, MMC, Navus Ventures and other investors.
Cambridge companies could do with more ambition, says UK tech gospeller Eben Upton
Eben Upton, CEO at Cambridge microcomputer innovator Raspberry Pi, has urged other tech companies in the Cluster to show more ambition in their global growth strategies.
More news
Tech trail
Oxford Innovation Finance invests in cutting-edge sensor technology to optimise crop growth
Oxford Innovation Finance’s EIS Growth Fund and OION Angel Network have invested in Gardin, a first real-time, remote and autonomous crop phenotyping SaaS platform, alongside LDV Capital, MMC, Navus Ventures and other investors.
Heavenly for Cellestial Health as it raises pre-seed funding
Cellestial Health, a pharmaceutical development spin-out from the University of Cambridge, has closed a £515,000 pre-seed equity funding round to accelerate the development of novel therapeutics targeting astrocytes, an often-overlooked cell type in the brain, with the first indication of Parkinson’s disease.
AI with the human touch
Genie AI is a very different kind of artificial intelligence company. And co-founder Rafie Faruq is a very different type of hot gospeller in the field.
Mode in the millions to progress chemical sensing innovation
Oxford University spin-out Mode Labs has secured £3 million investment to transform chemical sensing.
More Tech trail
Trade floor
Alchemab could net $415m from Eli Lilly deal
Alchemab Therapeutics, whose labs are in Cambridge UK, stands to scoop up to $415 million from Eli Lilly and Company following a landmark first deal of its kind for the startup.
Rein Therapeutics and Qureight broaden life science collaboration
A collaboration between Nasdaq quoted biopharma company Rein Therapeutics in Texas and Cambridge UK innovator Qureight Ltd could hold huge potential for the treatment of idiopathic pulmonary fibrosis (IPF).
Cambridge duo Mosaic and Astex agree cancer collaboration
Mosaic Therapeutics, a Cambridge-based targeted oncology therapeutics company resolving cancer’s complexity with new combination therapies, has in-licensed two clinical-stage oncology programs from Astex Pharmaceuticals.
CN Bio partners with Pharmaron to expand organ-on-a-chip capabilities
Cambridge-based organ-on-a-chip (OOC) innovator CN Bio has unveiled a strategic partnership with global R&D service provider Pharmaron. Under the agreement, Pharmaron will validate CN Bio’s PhysioMimix® technology across existing applications and collaborate on integrating OOC technologies into its R&D platform.
Boehringer Ingelheim and Tessellate Bio tackle hard-to-treat cancers in €500m deal
Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have struck a research collaboration and global licence agreement to develop first-in-class, oral precision treatments for people living with cancer.
More Trade floor
